Industry news
Astellas UK suspended from Association of the British Pharmaceutical Industry
Astellas UK has been suspended from the Association of the British Pharmaceutical Industry. It has been accused of sending doctors on a free trip to Milan to discuss the UK launch of prostate cancer drug Xtandi. This suspension comes after five complaints filed with the Prescription Medicines Code of Practice Authority about Astellas Europe and Astellas UK.